BioMark Diagnostics Inc.
BUX
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,422.89% | 4,234.77% | 1,386.54% | 1,391.02% | -74.01% |
| Total Receivables | 184.15% | 153.71% | 448.90% | 251.57% | 37.05% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 872.83% | 1,535.32% | 1,218.67% | 1,146.37% | -61.53% |
|
|
|||||
| Total Current Assets | 872.83% | 1,535.32% | 1,218.67% | 1,146.37% | -61.53% |
| Net Property, Plant & Equipment | -6.71% | -86.61% | -55.21% | -49.78% | -34.41% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 54.85% | 43.08% | 0.00% | -4.37% | 119.44% |
| Total Assets | 155.65% | 107.43% | 165.00% | 171.15% | -40.36% |
|
|
|||||
| Total Accounts Payable | -50.51% | -51.82% | 96.05% | 74.41% | 433.23% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -26.51% | -13.73% | -15.54% | 4.24% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 261.68% | -28.67% | -19.52% | -21.40% | -80.78% |
| Total Finance Division Other Current Liabilities | 8,596.55% | -3.23% | 0.00% | -6.45% | -7.94% |
| Total Other Current Liabilities | 8,596.55% | -3.23% | 0.00% | -6.45% | -7.94% |
| Total Current Liabilities | -14.81% | -33.86% | -2.11% | -6.68% | 2.42% |
|
|
|||||
| Total Current Liabilities | -14.81% | -33.86% | -2.11% | -6.68% | 2.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -26.51% | -13.73% | -15.54% | 4.24% |
| Capital Leases | -9.09% | -95.78% | -74.65% | -66.67% | -23.73% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -13.49% | -48.57% | -19.63% | -22.71% | -5.06% |
|
|
|||||
| Common Stock & APIC | 39.35% | 28.76% | 34.26% | 32.10% | -2.90% |
| Retained Earnings | -16.56% | -7.67% | -12.28% | -10.48% | -7.89% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 148.56% | 180.96% | 305.65% | 369.04% | -80.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 148.56% | 180.96% | 305.65% | 369.04% | -80.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 148.56% | 180.96% | 305.65% | 369.04% | -80.00% |
|
|
|||||